It became spokeswoman said on Monday the Basel-based drugmaker stood “100 percent” behing its statement about emicizumab and guidance for doctors treat bleed statemens.
A spokeswoman said on Monday the Basel-based drugmaker stood “100 percent” behind its statements about emicizumab and guidance for doctors treating bleeds.